Canoe Financial LP Astrazeneca PLC Transaction History

Canoe Financial LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$64.85 - $71.7 $138,325 - $152,936	-2,133 Reduced 0.38%	561,829 $51.7 Billion
Q2 2023 Aug 10, 2023	SELL	$69.91 - $75.81 $1.67 Million - $1.81 Million	-23,906 Reduced 4.07%	563,962 $40.4 Billion
Q1 2023 Apr 27, 2023	BUY	$63.15 - $71.6 $37.1 Million - $42.1 Million	587,868 New	587,868 $40.8 Billion

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Canoe Financial LP, based on Form 13F filings with the SEC.

Stay updated on Canoe Financial LP with notifications on news.